Risk Factors for Developing Candidemia after Gastrointestinal Perforation and/or Ischemia and Its Outcomes: A Matched

Myeongji Kim1, Nischal Ranganath1,2, Sofia Molina Garcia1

  • 1Division of Public Health, Infectious Diseases, and Occupational medicine, Mayo Clinic, Rochester, Minnesota, USA.

Surgical Infections
|April 23, 2026
PubMed
Abstract

Insights

Candidemia risk after gastrointestinal (GI) perforation is linked to upper GI injury and diffuse contamination, independent of intra-abdominal candidiasis (IAC). These factors can guide early antifungal strategies.

Area of Science:

  • Infectious Diseases
  • Surgical Critical Care
  • Mycology

Background:

  • Candidemia is a severe complication following gastrointestinal (GI) perforation and/or ischemia.
  • Existing research often groups candidemia with intra-abdominal candidiasis (IAC), obscuring candidemia-specific risk factors.
  • This study aimed to identify unique risk factors and outcomes associated with candidemia in this patient population.

Purpose of the Study:

  • To identify specific risk factors for candidemia in patients with GI perforation and/or ischemia.
  • To evaluate the outcomes associated with candidemia in this cohort.
  • To inform targeted surveillance and early antifungal treatment strategies.

Main Methods:

  • A single-center, retrospective matched case-control study was conducted.
  • Adult patients undergoing emergency surgery for GI perforation/ischemia were included.
  • Cases of candidemia were matched 4:1 to controls based on age, comorbidity index, and surgical year, with conditional logistic regression used for analysis.

Main Results:

  • Independent risk factors for candidemia included intra-abdominal candidiasis (IAC) (aOR: 5.51), upper GI injury (aOR: 4.28), and diffuse intra-abdominal contamination (aOR: 3.21).
  • Candida albicans was the most common species (41.7%), followed by C. glabrata (33.3%) and C. parapsilosis (12.5%).
  • Candidemia was associated with a significantly longer hospital length of stay (+13.97 days) but not with increased mortality or ventilation days.

Conclusions:

  • Upper GI injury and diffuse abdominal contamination are key independent risk factors for candidemia post-GI perforation/ischemia.
  • These findings suggest that readily identifiable operative features can guide targeted surveillance.
  • Selective early antifungal strategies may be beneficial, warranting prospective validation.

Related Concept Videos

Esophageal Perforation-I: Introduction01:22

Esophageal Perforation-I: Introduction

Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
835
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
1.0K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.6K